Phibro Animal Health pursues patent for ASF vaccine

Phibro Animal Health pursues patent for ASF vaccine

Researchers aim to create specific epitope-based vaccine, rather than attenuated live vaccine

Array

The Teaneck, New Jersey-based animal health company said its vaccine development process “involves the identification of immunogenic epitopes and proteins that show strong potential to form the basis for a vaccine against ASF.”